The First School of Clinical Medicine, Lanzhou University, 199 West Donggang R.D, Lanzhou, 730000, China.
Faculty of Hepatopancreatobiliary Surgery, The First Medical Center of Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
Surg Endosc. 2024 Sep;38(9):4926-4938. doi: 10.1007/s00464-024-11032-1. Epub 2024 Jul 8.
The safety and efficacy of robotic liver resection (RLR) for patients with hepatocellular carcinoma (HCC) have been reported worldwide. However, the exact role of RLR in HCC patients with liver cirrhosis is not sufficiently determined.
We conducted a retrospective study on consecutive patients with cirrhosis or non-cirrhosis who received RLR for HCC from 2018 to 2023. Data on patients' demographics and perioperative outcomes were collected and analyzed. Propensity score matching (PSM) analysis was performed. Multivariate logistic regression analysis was performed to determine the risk factors of prolonged postoperative length of stay (LOS) and morbidity.
Of the 571 patients included, 364 (64%) had cirrhosis. Among the cirrhotic patients, 48 (13%) were classified as Child-Pugh B. After PSM, the cirrhosis and non-cirrhosis group (n = 183) had similar operative time, estimated blood loss, postoperative blood transfusion, LOS, overall morbidity (p > 0.05). In addition, the intraoperative and postoperative outcomes were similar between the two groups in the subgroup analyses of patients with tumor size ≥ 5 cm, major hepatectomy, and high/expert IWATE difficulty grade. However, patients with Child-Pugh B cirrhosis had longer LOS and more overall morbidity than that of Child-Pugh A. Child-Pugh B cirrhosis, ASA score > 2, longer operative time, and multiple tumors were risk factors of prolonged LOS or morbidity in patients with cirrhosis.
The presence of Child-Pugh A cirrhosis didn't significantly influence the difficulty and perioperative outcomes of RLR for selected patients with HCC. However, even in high-volume center, Child-Pugh B cirrhosis was a risk factor for poor postoperative outcomes.
机器人肝切除术(RLR)治疗肝细胞癌(HCC)的安全性和有效性已在全球范围内得到报道。然而,RLR 在肝硬化 HCC 患者中的确切作用尚未得到充分确定。
我们对 2018 年至 2023 年期间因 HCC 接受 RLR 的肝硬化或非肝硬化连续患者进行了回顾性研究。收集并分析了患者的人口统计学和围手术期结局数据。进行了倾向评分匹配(PSM)分析。采用多变量逻辑回归分析确定术后住院时间(LOS)延长和发病率的危险因素。
在 571 例患者中,364 例(64%)患有肝硬化。在肝硬化患者中,48 例(13%)为 Child-Pugh B 级。PSM 后,肝硬化和非肝硬化组(n=183)的手术时间、估计出血量、术后输血、LOS、总发病率相似(p>0.05)。此外,在肿瘤大小≥5cm、大肝切除术和高/专家 IWATE 难度等级的亚组分析中,两组患者的术中及术后结局相似。然而,Child-Pugh B 级肝硬化患者的 LOS 和总发病率高于 Child-Pugh A 级肝硬化患者。Child-Pugh B 级肝硬化、ASA 评分>2、手术时间较长和多个肿瘤是肝硬化患者 LOS 延长或发病率的危险因素。
Child-Pugh A 级肝硬化并不显著影响选定 HCC 患者 RLR 的难度和围手术期结局。然而,即使在高容量中心,Child-Pugh B 级肝硬化也是术后不良结局的危险因素。